biocrates expands cross-platform compatibility

MxP® Quant 1000 kit now validated for SCIEX 7500

We’re pleased to announce that the MxP® Quant 1000, our most comprehensive kit for targeted metabolomics, has been validated for the SCIEX 7500 system. With 1,233 metabolites across 49 biochemical classes, the kit enables robust, quantitative measurements within a standardized workflow. This milestone reinforces biocrates’ vendor-neutral standing and cross-platform reproducibility across leading mass spectrometry systems.

Brand-new knowledge base

Guidance for every step of your kit workflow

Meet your shortcut to a smooth journey through every step of the kit workflow. The biocrates knowledge base brings together step-by-step guides, proven best practices, and expert insights – so you can get set up faster, troubleshoot with confidence, and get results you can trust. Plus, our new tool gets you support even quicker when you need it.

Development of a digital and biomarker test for bipolar disorder

Insights from Prof. Sabine Bahn | 5P webinar

In this talk, Prof. Sabine Bahn spotlights a two-stage test for clearer mood-disorder diagnosis combining (1) an online questionnaire capturing symptoms and demographics, paired with (2) a metabolomics biomarker signature developed from biocrates’ MxP® Quant 500 kit on self-collected dried blood spots. Results include 6- and 12-month follow-ups and a digital triage platform from the Bahn lab and Psyomics, now used across NHS trusts.

Metabolic phenotyping services

Expert support from study design to actionable results

Keep your studies moving with biocrates’ metabolic phenotyping – ISO-certified, quality-controlled analytics across the metabolic spectrum. Choose from 12 targeted assays quantifying over 1,500 metabolites. We support you end-to-end – sampling and shipment, project management, data analysis/biostatistics, and expert interpretation with pathway visuals.

biocrates expands cross-platform compatibility

MxP® Quant 1000 kit now validated for Bruker EVOQ® DART-TQ⁺

We’re proud to announce that the MxP® Quant 1000, our most comprehensive kit, is now optimized and validated on the Bruker EVOQ® DART-TQ⁺ mass spectrometer (RUO). This marks a milestone – the first biocrates standardized kit for broad quantitative metabolomics on a Bruker triple quadrupole platform.
Covering 1,233 metabolites across 49 biochemical classes, the MxP® Quant 1000 kit enables robust, reproducible quantification across diverse sample matrices. Researchers can now benefit from the same standardized workflow across Bruker and other major mass spectrometer platforms, continuing biocrates’ long-lasting vendor neutrality and cross-platform reproducibility.

Interrogating the metabolome in colorectal cancer

Metabolomic fingerprints for early detection and therapy monitoring

Colorectal cancer and its precursors display unique metabolomic signatures that hold promise for clinical translation. In this insightful presentation, Prof. Oliver F. Bathe from the University of Calgary discusses how these metabolic fingerprints can be harnessed for early detection and for tracking therapeutic response. His research highlights the potential of metabolomics to refine diagnosis and transform precision oncology.

MetIDQ support ending soon

Migrate to WebIDQ now

Our legacy software MetIDQ will reach the end of its support lifecycle on December 31, 2025.
If you’re still using MetIDQ, now is the time to migrate to WebIDQ – our cloud-based workflow and analysis software. Click the button for full details and support information.

Energy metabolism in cancer

Mechanisms, plasticity, and applications

Cancer cells reprogram energy metabolism to fuel rapid growth, often relying heavily on glycolysis and glutaminolysis. Lactate and other oncometabolites generated in the TCA cycle drive proliferation and immune evasion. Metabolomics helps uncover these processes. With biocrates’ kits, key metabolites can be quantified and biomarkers like the pyruvate-to-lactate ratio investigated, offering insights into tumor biology and potential therapies.

🎧 The Metabolomist podcast 🎧

Episode 6 – Building community & navigating publishing

In this episode, Alice Limonciel and María Eugenia Monge discuss why it matters to build community in science, how to navigate the publishing world when establishing new methods in your lab, and the region-specific implications of the implementation of metabolomics in the clinics.

Transforming medicine with metabolomics

Participatory medicine – Part 5 of 5

In this month’s 5P medicine article, we look at how metabolomics drives participatory medicine by giving patients a more active role in managing their health. Discover how at-home sampling, tailored reference ranges, and quantitative metabolomics enable individuals to track their health, support remote care, and turn personal data into actionable insights for better outcomes.

Using biocrates’ MxP® Quant 1000 kit across MS platforms

Technical note

Our latest technical note confirms the reproducibility and robustness of the MxP® Quant 1000 kit across various MS platforms and labs. High correlation and broad coverage were observed on all instruments. Paired with the AI-powered WebIDQ workflow manager, this solution streamlines data processing and ensures consistent, high-quality results, regardless of the MS system used.

biocrates becomes part of Bruker Corporation

A new chapter in quantitative metabolomics

We are excited to share that biocrates life sciences gmbh has joined Bruker Corporation, marking a major milestone in the evolution of quantitative metabolomics. As a global leader in mass spectrometry-based metabolite and lipid profiling, biocrates will continue to drive innovation and accessibility in multiomics – now with the expanded support and reach of Bruker. This partnership strengthens our shared mission to deliver reproducible, standardized solutions for precision research worldwide.